Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
70 Leser
Artikel bewerten:
(0)

Research and Markets - Global Vascular Access Devices Outlook 2022 - Anticipated to Grow 6% - Key Vendors are AngioDynamics, Medtronic & Smiths Medical

DUBLIN, Nov 22, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Vascular Access Devices Outlook 2022" report to their offering.

The growing incidence of chronic diseases, such as cancer, diabetes, and blood pressure, has further propelled the need for hospitalization. A majority of patients who get hospitalized receive some sort of vascular access treatment during their stay. The vascular access devices are intended for various purposes such as providing parenteral nutrition, transfusion of blood product, providing avenue for hemodynamic monitoring, providing avenue for diagnostic testing, and administration of fluids and medications.

The global vascular access devices market is anticipated to grow at a CAGR of 6% during the forecasted period (2016-2022). The market growth is expected mainly due to the growing strategic alliances, technological advancements, growing incidences of cancer and renal disorders, increasing awareness about vascular access devices, and rising incidences of obesity.

Based on product type, peripheral devices are expected to dominate the market. However, the central vascular access devices segment is expected to witness the highest growth in the coming years. In the central vascular access devices, the leading and fastest-growing segment is the Peripherally Inserted Central Catheters (PICCs), which has a wide range of applications and are commonly used for delivering chemotherapy and antibiotics, as well as drawing blood.

In terms of application of the devices, medication administration is most common application observed amongst all the types of vascular access devices; however, hemodialysis monitoring has an increasing usage in patients with renal diseases. Furthermore, in terms of route of administration, intravenous route accounts for the largest share in the vascular access devices market. On the other hand, based on end-user, the hospital segment is expected to account for largest share.

Based on geography, North America is the largest market for vascular access devices market. However, the Asia-Pacific market is expected to witness the highest growth due to rapidly aging population, increasing hospitalization rate, and growing focus of various players in this region.

Companies Mentioned:

  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson And Company
  • C. R. Bard, Inc.
  • Fresenius Medical Care
  • Medical Components, Inc.
  • Medtronic plc
  • NIPRO Medical Corporation
  • Smiths Medical
  • Teleflex Incorporated

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. Vascular Access Devices - An Introduction

4. Market Dynamics

5. Vascular Access Devices Market Outlook 2022

6. Vascular Access Devices Market, By Product

7. Vascular Access Devices Market, By Application

8. Vascular Access Devices Market, By Insertion Route

9. Vascular Access Devices Market, By End User

10. Vascular Access Devices Market, By Region

11. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/22zq64/global_vascular

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.